Eliminating Cervical Cancer: A Global Call to Action

Every year, cervical cancer claims the lives of over 340,000 women, predominantly in low- to middle-income countries. Despite being one of the most preventable forms of cancer through vaccination and early detection, this disease remains a major health concern, ranking as the fourth most prevalent cancer among women worldwide.

The WHO’s Global Strategy

In 2020, the World Health Organization (WHO) introduced the Global Strategy to Accelerate the Elimination of Cervical Cancer, which sets forth ambitious targets known as “90-70-90”. These goals encompass the vaccination of 90% of girls against human papillomavirus (HPV) by the age of 15, 70% of women screened using a high-performance test by the age of 35 and again by 45, and 90% of women identified with cervical disease receiving treatment. However, achieving these targets faces significant hurdles due to disparities in healthcare resources, infrastructure, and capacity for implementation.

Special Issue on Cervical Cancer

To commemorate the 30-year anniversary of the Fourth World Conference on Women and the upcoming 2025 World Women’s Summit in Beijing, Cancer Biology & Medicine has released a special issue focused on the elimination of cervical cancer. This special issue is guest-edited by Professor Youlin Qiao from the Chinese Academy of Medical Sciences and Peking Union Medical College, showcasing global disparities, contributions from China, and necessary innovations in science and policy to foster progress.

Key Contributions to the Issue

The publication compiles ten insightful articles covering a range of topics related to cervical cancer. Highlights include:

• An editorial from the International Agency for Research on Cancer (IARC/WHO) discussing global disparities and China’s role.
• A perspective piece on utilizing policy modeling to inform resource-sensitive strategies in developing countries.
• An original study detailing the trends in cervical cancer burden within China from 2000 to 2020, compared to other Asia-Pacific nations.
• First international evaluation of the bilingual digital colposcopy education tool, iDECO, which has shown significant enhancements in diagnostic accuracy.
• Research on a promising therapeutic multi-epitope protein vaccine targeted at HPV16, demonstrating notable tumor regression in preclinical evaluations.

Innovations and Future Directions

The special issue also delves into various groundbreaking approaches, such as:

• Assessing willingness for HPV vaccination.
• Developing innovative triage algorithms tailored for rural settings in China.
• Creating intelligent digital platforms aimed at population-based screening.
• Analyzing the economic implications of government-led programs aimed at combating cervical cancer.

Collective Commitment for Women’s Health

“Cervical cancer is the only malignancy we can realistically eliminate through vaccination, screening, and early treatment. This special issue demonstrates the collective knowledge and innovation needed to achieve that goal. By combining science, policy, and equity, we can ensure that no woman is left behind in the global drive to eliminate cervical cancer.”

Professor Youlin Qiao, Guest Editor of the issue

The release of this special issue aligns perfectly with a renewed global focus on women’s health as highlighted in the upcoming 2025 World Women’s Summit. By providing evidence-based insights across diverse fields, Cancer Biology & Medicine aims to stimulate international collaboration and prompt actionable steps. The elimination of cervical cancer represents not only a critical public health goal but also a significant achievement in the pursuit of gender equity and global health justice.

A Call to Action

As the world approaches a transformative milestone in health, this special issue serves as both a progress report and an urgent call to action. The elimination of cervical cancer is achievable in our lifetime, but this requires a united global effort.